arrow
J

Jinliang Wang

Chinese PLA General Hospital
H指数:26
被引数:1,867

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Efficacy, safety, and exploratory biomarker analysis of envafolimab plus carboplatin and etoposide as first-line treatment for extensive-stage small-cell lung cancer: a prospective, single-arm, phase II trial

envafolimab联合卡铂和依托泊苷作为广泛期小细胞肺癌一线治疗的疗效、安全性及探索性生物标志物分析:一项前瞻性、单臂、II期试验

2025-10-080
OAAI
Comparison of the effectiveness of alectinib versus crizotinib followed by alectinib in patients with ALK-positive advanced non-small-cell lung cancer in real-world setting and in the ALEX study

比较阿来替尼与克唑替尼序贯阿来替尼在ALK阳性晚期非小细胞肺癌患者中的真实世界疗效及ALEX研究中的疗效

2025-04-010
OA
Chinese expert consensus on the diagnosis and treatment of bone metastasis in lung cancer (2022 edition)
2023-12-011
OAAI
Early autoimmunity and outcome in virus encephalitis: a retrospective study based on tissue-based assay
2023-05-2411
OAAI
An outbreak of Mycobacterium marinum infection associated with handling seabass in China
2022-11-050
OAAI
Dynamics of Serum Tumor Markers Can Serve as a Prognostic Biomarker for Chinese Advanced Non-small Cell Lung Cancer Patients Treated With Immune Checkpoint Inhibitors

血清肿瘤标志物的动态变化可作为免疫检查点抑制剂治疗的中国晚期非小细胞肺癌患者的预后生物标志物

2020-06-1038
OAAI